| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus epidermidis (C621) |
- |
- |
32 － ? |
Dermaseptin (DER-M)  |
181 |
| Staphylococcus epidermidis (C621) |
- |
- |
>64 － ? |
Bactenecin |
181 |
| Staphylococcus epidermidis (C621) |
- |
- |
>64 － ? |
CER-M |
181 |
| Staphylococcus epidermidis (C621) |
- |
- |
>64 － ? |
Misgurin |
181 |
| Staphylococcus epidermidis (C621) |
- |
- |
>64 － ? |
P-CER (Peptide) |
181 |
| Staphylococcus epidermidis (C621) |
- |
- |
64 － ? |
Pleurocidin |
181 |
| Staphylococcus epidermidis (CAN-ICU 61589 + meticillin-resistant) |
- |
2 |
? － ? |
Benzalkonium chloride |
1524 |
| Staphylococcus epidermidis (CIP 106510) |
- |
- |
4 － ? |
Gentamicin (Gentamycin, Garamycin) |
891 |
| Staphylococcus epidermidis (CIP 106510) |
- |
- |
8 － ? |
Thymoquinone |
891 |
| Staphylococcus epidermidis (CIP 106510) |
- |
- |
16 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
891 |
| Staphylococcus epidermidis (CIP 106510) |
- |
- |
620 － ? |
Mentha pulegium (Essential oil) |
902 |
| Staphylococcus epidermidis (CIP 106510) |
- |
- |
1250 － ? |
Mentha longifolia (Essential oil) |
902 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
- |
<=0.008 － 8 |
Tobramycin (Tobrex, Nebcin) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
- |
0.015 － 0.03 |
Besifloxacin (Besivance) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.06 |
- |
0.03 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.06 |
- |
0.06 － ? |
Gatifloxacin (Tequin) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
- |
<=0.06 － 2 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
- |
0.12 － ? |
Ciprofloxacin (Planktonic) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
- |
0.12 － ? |
Levofloxacin (Levaquin, Quixin) |
1467 |
| Staphylococcus epidermidis (ciprofloxacin-susceptible + methicillin-resistant) |
>8 |
- |
0.25 － >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1467 |
| Staphylococcus epidermidis (clinical isolate + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － ? |
Rifampicin (Rifampin) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-resistant) |
0.25 |
0.25 |
≤0.06 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-resistant) |
2 |
2 |
2 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-resistant) |
2 |
16 |
0.12 － >=128 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-resistant) |
2 |
16 |
0.5 － 32 |
Teicoplanin (Targocid) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-susceptible) |
≤0.06 |
≤0.06 |
≤0.06 － 32 |
Rifampicin (Rifampin) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-susceptible) |
0.25 |
0.25 |
≤0.06 － 1 |
Quinupristin/Dalfopristin (Synercid) |
477 |
| Staphylococcus epidermidis (clinical isolate + methicillin-susceptible) |
0.25 |
16 |
0.12 － 32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
477 |